Ivrea, Inc.

Quincy, MA 02169

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $1.19MM
First Award Date 06/01/00
Most Recent Award Date 09/15/04

Key Personnel

Last Name Name Awards Contact
Cattaneo Maurizio V Cattaneo 5
Lee Ike W Lee 1

6 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/04 - 03/14/05
PI: Ike W Lee

DESCRIPTION (provided by applicant): Approximately 600,000 people die of cardiac cell death-related diseases such as coronary heart disease (CHD), acute myocardial infarct (AMI) and congestive heart failure (CHF). Current strategies for cardiac regeneration have generated a great deal of enthusiasm and stem cell technology in particular is been ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/27/04 - 03/31/05

DESCRIPTION (provided by applicant): Malignant melanoma's incidence is increasing by 2.7% annually even as most other cancers are experiencing a decline in incidence. The long-term objective of this project is to commercialize a topical formulation containing retinoic acid (ATRA) for subjects with dysplastic nevi at a higher risk of developing m...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/03 - 03/31/04

DESCRIPTION (provided by applicant): Malignant melanoma's incidence is increasing by 2.7% annually even as most other cancers are experiencing a decline in incidence. The long-term objective of this project is to commercialize a topical formulation containing retinoic acid (ATRA) for subjects with dysplastic nevi at a higher risk of developing m...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/02 - 03/31/03

DESCRIPTION (provided by applicant): Osteoarthritis (OA) is a common disabling disorder for which no good medical remedy currently exists. As a result, many patients take Glucosamine, a nutritional supplement, for the treatment of their OA symptoms, because of its high level of safety compared to traditional anti-inflammatory medications. Howev...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/01 - 09/30/02

The development of a topical estrogen patch including a biodegradable chitosan-based biopolymer (CB) to accelerate wound healing in the elderly patients is proposed. Delays in acute cutaneous wound healing lead to local infections, wound dehiscence, and a transition toward chronic, nonhealing wound. Recent clinical data have shown the benefit of...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/00 - 11/30/00

Development of a percutaneous delivery system based on a natural biopolymer is proposed for the reduction of irritation caused by the chronic topical delivery of all-trans-retinoic acid (ATRA). A national Phase II trial led by the Eastern Cooperative Oncology Group is now investigating the effects of topical ATRA for the chemoprevention of melan...